Spots Global Cancer Trial Database for Unrelated Double Umbilical Cord Blood Units Transplantation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Unrelated Double Umbilical Cord Blood Units Transplantation
Official Title: Evaluation of Benefit and Side Effects of Double Umbilical Cord Blood Units Stem Cell Transplantation in Hematologic Malignancies
Study ID: NCT01015742
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the safety and feasibility of unrelated double umbilical cord blood units Transplantation in patients with haematological malignancies using Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin, methylprednisolone as GVHD prophylaxis.
Detailed Description:
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hematology-Oncology & SCT Research Center, Tehran, , Iran, Islamic Republic of
Contact Details
Name: Amir Ali Hamidieh, MD
Affiliation: Hematology-Oncology and SCT Research Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
